U Creutzig, M Zimmermann, J Ritter, D Reinhardt, J Hermann, G Henze, H Jürgens, H Kabisch, A Reiter, H Riehm, H Gadner, G Schellong, for the AML-BFM Study Group: Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. In: Leukemia. Band19, Nr.12, Dezember 2005, ISSN0887-6924, S.2030–2042, doi:10.1038/sj.leu.2403920 (nature.com [abgerufen am 23. September 2023]).
U Creutzig, M Zimmermann, J Ritter, D Reinhardt, J Hermann, G Henze, H Jürgens, H Kabisch, A Reiter, H Riehm, H Gadner, G Schellong, for the AML-BFM Study Group: Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. In: Leukemia. Band19, Nr.12, Dezember 2005, ISSN0887-6924, S.2030–2042, doi:10.1038/sj.leu.2403920 (nature.com [abgerufen am 23. September 2023]).
U Creutzig, M Zimmermann, J Ritter, D Reinhardt, J Hermann, G Henze, H Jürgens, H Kabisch, A Reiter, H Riehm, H Gadner, G Schellong, for the AML-BFM Study Group: Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. In: Leukemia. Band19, Nr.12, Dezember 2005, ISSN0887-6924, S.2030–2042, doi:10.1038/sj.leu.2403920 (nature.com [abgerufen am 23. September 2023]).